Light Rain 47°
Tag:

Pfizer-BioNTech

Lifestyle
COVID-19: Here's Name Of New Booster Targeting Omicron Strain, What To Know, How To Get Vaccine COVID-19: Here's Name Of New Booster Targeting Omicron Strain, What To Know, How To Get Vaccine
Covid-19: Here's Name Of New Booster Targeting Omicron Strain, What To Know, How To Get Vaccine Health experts are recommending the use of updated COVID-19 booster vaccines to protect people from the most prevalent subvariants of the virus currently circulating. The newly-approved boosters are officially named "bivalent vaccines" that target the original strain of COVID-19 and what is now the predominant subvariant of Omicron, BA.5., according to a report from the University of Texas MD Anderson Cancer Center with Dr. David Tweardy, the head of the Department of Infectious Diseases. “The updated COVID-19 boosters are formulated to better protect against the most recently circulating C…

SHARE

by Nicole Valinote
News
COVID-19: FDA Expands Eligibility For Pfizer Booster To Children 5 Through 11 COVID-19: FDA Expands Eligibility For Pfizer Booster To Children 5 Through 11
Covid-19: FDA Expands Eligibility For Pfizer Booster To Children 5 Through 11 Federal health officials have granted emergency use authorization for a booster dose of the Pfizer-BioNTech COVID-19 vaccine in children. On Tuesday, May 17, the US Food and Drug Administration (FDA) announced that it is expanding eligibility for boosters to include children between the ages of 5 and 11 years old. That age group will be permitted to receive their booster shot five months after completing their initial COVID-19 vaccination series, officials said. FDA Commissioner Robert Califf said that while data shows COVID-19 is less severe in children, the vaccine and boosters can help …

SHARE

by Zak Failla
News
COVID-19: FDA Advisory Panel Votes To Recommend Moderna Booster For Certain Groups Of People COVID-19: FDA Advisory Panel Votes To Recommend Moderna Booster For Certain Groups Of People
Covid-19: FDA Advisory Panel Votes To Recommend Moderna Booster For Certain Groups Of People A US Food and Drug Administration (FDA) advisory panel has endorsed emergency authorization for Moderna’s half-dose COVID-19 vaccine booster shot for certain groups of people. The latest guidance from the feds calls for Moderna booster shots to be administered at least six months following the completion of the two-dose vaccination process for certain groups. Currently, the booster is recommended for people 65 and older and Americans between the ages of 18 and 64 who are immunocompromised and at a greater occupational risk of exposure or severe side effects from the virus. Related story …

SHARE

by Zak Failla
News
COVID-19: Moderna Asks FDA To Approve Vaccines For Those Ages 12 To 17 COVID-19: Moderna Asks FDA To Approve Vaccines For Those Ages 12 To 17
Covid-19: Moderna Asks FDA To Approve Vaccines For Those Ages 12 To 17 Moderna has requested an emergency use authorization from the Food and Drug Administration (FDA) for its COVID-19 vaccine in adolescents between the ages of 12 and 17. The company announced that clinical trials have shown that the vaccine has a 93 percent efficacy rate among adolescents, and has been proven to be safe. If approved, it would be the second COVID-19 vaccine authorized for adolescents, joining the Pfizer-BioNTech vaccine, which was given the green light for use earlier this month. In their study, Moderna found no cases of COVID-19 in participants who received two doses of th…

SHARE

by Zak Failla
News
COVID-19: Vaccine 'Safe, Highly Effective' In Kids 12-17, Moderna Says, Will Seek FDA Approval COVID-19: Vaccine 'Safe, Highly Effective' In Kids 12-17, Moderna Says, Will Seek FDA Approval
Covid-19: Vaccine 'Safe, Highly Effective' In Kids 12-17, Moderna Says, Will Seek FDA Approval Moderna’s COVID-19 vaccine has proven effective and safe for adolescents and teens between the ages of 12 and 17, the company announced, as it prepares to seek federal authorization. The company announced that clinical trials have shown that the vaccine has a 93 percent efficacy rate among adolescents, and has been proven to be safe. Moderna officials said that they plan to apply for federal approval from the Food and Drug Administration (FDA) to use the vaccine in that age group in June. If approved, it would be the second COVID-19 vaccine authorized for adolescents, joining the Pfizer-Bi…

SHARE

by Zak Failla
News
COVID-19: New Info Emerges On Who's More Likely To Experience Vaccine Side Effects COVID-19: New Info Emerges On Who's More Likely To Experience Vaccine Side Effects
Covid-19: New Info Emerges On Who's More Likely To Experience Vaccine Side Effects With an average of about three million Americas receiving COVID-19 vaccines each day, new information has emerged as to who's most susceptible to side effects. Side effects are a sign that the body is responding to the dose, according to medical experts.  One of them, Dr.Allison Arwady, the Chicago Department of Public Health Commissioner, said younger people are more likely to experience side effects because they "have more robust immune system broadly," according to a report by NBC 5 Chicago. Women are also more likely to report side effects than men, Arwady said, noting estrog…

SHARE

by Joe Lombardi
News
COVID-19: This Is When Children Can Start Getting The Vaccine, Fauci Says COVID-19: This Is When Children Can Start Getting The Vaccine, Fauci Says
Covid-19: This Is When Children Can Start Getting The Vaccine, Fauci Says An estimated timeline for when children and teens will be able to get COVID-19 vaccinated was recently laid out by Dr. Anthony Fauci. Some of the youngest children won’t be vaccinated until 2022. On Sunday, Feb. 28, Fauci, head of the National Institute of Allergy and Infectious Diseases, said that high school students could begin receiving the vaccine in the fall. Younger children, he said, will likely have to wait until early next year. During an interview on NBC’s “Meet the Press” Fauci said that more research needs to be done to make sure the available COVID-19 vaccines are safe for…

SHARE

by Kristin Palpini
News
COVID-19: Johnson & Johnson Releases Trial Results For One-Dose Vaccine COVID-19: Johnson & Johnson Releases Trial Results For One-Dose Vaccine
Covid-19: Johnson & Johnson Releases Trial Results For One-Dose Vaccine Some relief may be on the way for the millions of people awaiting their turn to receive the COVID-19 vaccine. Johnson & Johnson has been developing a single-dose vaccine for COVID-19, which has an efficacy rate of approximately 72 percent, potentially bringing another provider into the mix as vaccines for the virus have become a valuable and scarce commodity. If it is ultimately approved by federal health officials, the Johnson & Johnson vaccine would join Pfizer and Moderna on the market, both of which require two doses administered approximately three weeks apart. However, the ef…

SHARE

by Zak Failla
News
COVID-19: What Happens To Me If I Don't Take The 2nd Vaccine Dose On Time? COVID-19: What Happens To Me If I Don't Take The 2nd Vaccine Dose On Time?
Covid-19: What Happens To Me If I Don't Take The 2nd Vaccine Dose On Time? With the COVID-19 vaccine becoming increasingly available, many people are wondering about the two-visit/two-dose treatment - and what happens if you miss that second required dose or take it really late. Concerns are arising about what the impacts are for people who get the first, but not the second dose of the mRNA-type COVID-19 vaccine. There are also questions about whether a person can mix vaccines - taking different products for the first and second doses. Data is limited, but it seems that some people can handle a little deviation from the vaccination schedule just fine. It is bette…

SHARE

by Kristin Palpini